Pharmaceutical Products
Displayed on this page are pharmaceutical products in development by Innovative Potential™.
All Known EAC Molecules
Do you have a highly sensitive or short-lived compound that you are having difficulty bringing to market?
​​
Well now you can thanks to the wonders of EAC!
​
Chaperone your molecule for electrochemical activation with Innovative Potential to protect and extend the real-world functionality, and profitability, of your next molecule!
​​
EAC also applies to all known bioactivatable molecules!
All EAC Antibiotics
Ever consider chaperoning a champion like Penicillin to stop environmentally-acquired antibiotic resistant strains from developing?
​
You should.
I did, and now I'm telling you.
This one is kind've important.
​
The EAC-antibiotics are capable of being brought to market with a CGP-only removable chaperone group.
This CGP-specific leaving group can preserve an antibiotic's potency against antibiotic resistant strain development.
​
The CGP is patented under Innovative Potential.
Electramide™
Electramide™ is a cyclophoshamide formulation in a CGP-friendly electrolyte solution.
​
Electramide™ is a specialty cyclophosphamide formulation for CGP and EAC drug development work including electrolysis assessments, in vitro bioassay screening, and in vivo testing.
​
Electramide™ is not a regulated medical product, and is for research purposes only.
Electramide™ is not for human or veterinary use.
Electrophen™
Electrophen™ is an acteaminophen formulation in a CGP-friendly electrolyte solution.
​
Electrophen™ is a specialty acetaminophen formulation for CGP and EAC drug development work including electrolysis assessments, in vitro bioassay screening, and in vivo testing.
​
Electrophen™ is not a regulated medical product, and is for research purposes only.
Electrophen™ is not for human or veterinary use.
ProLact™
ProLact™ is a live-culture dairy product that contains a genetically modified organism (GMO) for lactose intolerant people.
​
ProLact™ is a GMO-probiotic that inhabits the gut microbiome for approximatley one week post consumption, and has been modified to constituitively express and secrete human lactase enzymes into the lumen of the small intestine.
​
ProLact™ digests lactose using human lactase enzymes for people who are lactose intolerant.
​
ProLact™ is currently in development and not a regulated medical or food product, and is strictly for research purposes only, for now.
Not for human or veterinary use.